Ann Cohen - 24 Jun 2026 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Reporting relationship
Director
Issuer ticker
NAGE
Reported as of
24 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Jun 2026, 18:01:21 UTC
Prior SEC filing
25 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeong James Lee, Attorney-in-Fact

Key filing fact

Ann Cohen filed Form 4 for Niagen Bioscience, Inc. (NAGE) on 26 Jun 2026.

Key facts

  • This page summarizes Ann Cohen's Form 4 filing for Niagen Bioscience, Inc. (NAGE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 26 Jun 2026, 18:01.

Change

  • Previous filing in this sequence was filed on 25 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001923843 Primary reporting owner

Cohen Ann

Relationship
Director
Address
10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Signature date
26 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NAGE transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+31,746
Change %
Price
$0.000000*
Shares after
31,746
Date
24 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,746
Exercise price
$3.45
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option vests 100% on June 24, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .